Title: "Shedding Light on AMD"
Dr. Anthony Adamis, MD, is Senior Vice President and Global Head of Ophthalmology, Immunology, Infectious Disease & Metabolism, Clinical Science at Genentech, a member of the Roche Group.
Dr. Adamis is best known for his co-discovery of the role of VEGF in ocular disease. Previously, he co-founded Eyetech (2000) and Jerini Ophthalmic (2007). At Eyetech, Dr. Adamis helped lead the team that obtained FDA approval for the first anti-VEGF drug in ophthalmology. From 1991 to 2002, Dr. Adamis was on the full time faculty of the Harvard Medical School and was co-director of the Ocular Angiogenesis Laboratory at the Massachusetts Eye and Ear Infirmary. His research is focused on AMD and diabetic retinopathy, as well as ocular drug delivery. He received his M.D. with Honors from the University of Chicago, and completed his ophthalmology residency at the University of Michigan and fellowship in corneal disease at the Massachusetts Eye and Ear Infirmary. His research training in vascular biology was with Dr. Judah Folkman at the Children’s Hospital of Boston.
227 CMWT College of Medicine West Tower
Lectures, Seminars and Meetings/Semester Dates and Holidays